Drug Tested in Mice Shows Promise for Treating Pulmonary Fibrosis

A mysterious lung disease affecting millions of people is the subject of a recent article published in Nature. The condition, pulmonary fibrosis, is highlighted in research published online on 04 June 2026.

According to the report, a drug tested in mice shows promise in addressing this condition. The therapy operates by activating a protein. Researchers suggest that this activation could stop pulmonary fibrosis from progressing. The article, titled "This mysterious lung disease affects millions of people — but a drug tested in mice shows promise," outlines these findings.

The study is accessible via the digital object identifier doi:10.1038/d41586-026-01789-x. The research provides insight into potential therapeutic avenues for the disease.